VERA THERAPEUTICS INC (VERA:NASDAQ)
$45.04 4.11 (10.0415%)
Analysed VERA THERAPEUTICS INC (VERA:NASDAQ) News Sources
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10-04-2026
yahoo.com
Is Vera Therapeutics (VERA) Still Attractive After An 87% One Year Share Price Surge
10-04-2026
yahoo.com
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
01-04-2026
247wallst.com
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
25-03-2026
yahoo.com
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
21-03-2026
fool.com
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know
21-03-2026
fool.com
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know
21-03-2026
fool.com
Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish
21-03-2026
fool.com
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
20-03-2026
fool.com
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment
16-03-2026
fool.com
What is the current price of VERA THERAPEUTICS INC (VERA:NASDAQ)?
The current price of VERA THERAPEUTICS INC (VERA:NASDAQ) is $45.04.
VERA THERAPEUTICS INC (VERA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is $4.11.
VERA THERAPEUTICS INC (VERA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is 10.0415%.
What is the most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ) is .
SEC-8K** Filing Available For VERA THERAPEUTICS INC (VERA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.